CoChat

Imaging of Sarcopenia in Type 2 Diabetes Mellitus

Open access
Wang, Dingyue, Zhang, Gaosen, Yu, Yana, Zhang, Zhen · 2024 · Clinical Interventions in Aging

The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index; 19 of the 107 sources its claims cite were checked for support.

Abstract

Sarcopenia is an age-related condition characterized by the loss of skeletal muscle mass, muscular strength, and muscle function. In older adults, type 2 diabetes mellitus (T2DM) constitutes a significant health burden. Skeletal muscle damage and deterioration have emerged as novel chronic complications in patients with diabetes, often linked to their increased longevity. Diabetic sarcopenia has been associated with increased rates of hospitalization, cardiovascular events, and mortality. Nevertheless, effectively managing metabolic disorders in patients with T2DM through appropriate therapeutic interventions could potentially mitigate the risk of sarcopenia. Utilizing imaging technologies holds substantial clinical significance in the early detection of skeletal muscle mass alterations associated with sarcopenia. Such detection is pivotal for arresting disease progression and preserving patients' quality of life. These imaging modalities offer reproducible and consistent patterns over time, as they all provide varying degrees of quantitative data. This review primarily delves into the application of dual-energy X-ray absorptiometry, computed tomography, magnetic resonance imaging, and ultrasound for both qualitative and quantitative assessments of muscle mass in patients with T2DM. It also juxtaposes the merits and limitations of these four techniques. By understanding the nuances of each method, clinicians can discern how best to apply them in diverse clinical scenarios.

Overview

CoChat Summary

TL;DR

This narrative review summarizes imaging modalities—DXA, CT, MRI, and ultrasound—for qualitative and quantitative assessment of muscle mass in patients with type 2 diabetes mellitus (T2DM) and sarcopenia. It compares their advantages and limitations and argues that imaging is important for early detection, monitoring, and guiding interventions in diabetic sarcopenia.

Key findings

  • Sarcopenia is defined as progressive and generalized loss of skeletal muscle mass and strength; muscle strength declines by 20–40% during the seventh and eighth decades of life.
  • DXA-based low muscle mass cutoffs are ALMI < 5.5 kg/m² in women and < 7.0 kg/m² in men per EWGSOP, while AWGS suggests ALMI < 5.7 kg/m² in women and < 7.0 kg/m² in men for Asian populations.
  • CT commonly uses skeletal muscle index cutoffs of 39–41 cm²/m² for females and 52–55 cm²/m² for males, but there is no universally recognized CT-based standard for sarcopenia diagnosis.
  • Ultrasound shear-wave elastography reported average gastrocnemius stiffness of 12.51 ± 2.56 kPa in the relaxed state and 81.74 ± 15.77 kPa in the contracted state; MRI is described as the gold standard for body composition but is limited by cost, complexity, and availability.

Methods

  • Narrative review of imaging techniques for sarcopenia in T2DM, focusing on dual-energy X-ray absorptiometry (DXA), computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound (US), with additional discussion of bioelectrical impedance analysis (BIA).
  • The paper synthesizes prior literature and guidelines, including EWGSOP and AWGS definitions and diagnostic approaches, rather than presenting primary data.
  • It compares modalities by measures, simplicity, cost, validity, clinical application, and research application, and discusses associations between T2DM, muscle mass, exercise, and hypoglycemic medications.

Limitations

  • Stated: CT lacks a universally recognized sarcopenia diagnostic standard because of population and criteria variations, and has high radiation dose, cost, and operational complexity; MRI has high costs, complexity, limited availability, and no standardized imaging protocols or biomarkers; US measurement of intermuscular adipose tissue lacks accuracy and consistency due to scanner subjectivity, probe angle, and pressure; BIA accuracy can be substantially affected by hydration status in older adults with T2DM.
  • Stated: DXA may overestimate thigh muscle mass, especially in severely obese women, due to body thickness and hydration, and accuracy can be compromised if body length or arm spacing exceeds scanning dimensions.
  • Evident from the text: this is a narrative review without a described systematic search strategy, meta-analysis, or primary cohort, so findings depend on the selected cited literature and do not provide new empirical estimates.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2147/cia.s443572

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Screening and diagnostic approach for sarcopenia termed “Find-Assess-Confirm-Severity”. Adapted from Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T et al Sarcopenia: revised European consensus on definition and diagnosis. Age and ageing. 2019;48(1):16–31.1
Figure 1 Screening and diagnostic approach for sarcopenia termed “Find-Assess-Confirm-Severity”. Adapted from Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T et al Sarcopenia: revised European consensus on definition and diagnosis. Age and ageing. 2019;48(1):16–31.1CC BY-NC · PubMed Central
Figure 2 Effects of hypoglycemic drugs and exercise on muscle mass and performance.
Figure 2 Effects of hypoglycemic drugs and exercise on muscle mass and performance.CC BY-NC · PubMed Central

Verification

Claims the paper makes

15 Valid · 1 Not valid · 69 Not checked · 5 Own results and interpretations

38 more claims · 4 with their cited sources checked

Create a free account to see all 90 claims and to verify the 88 references still open.

See all claims — free account
  • Probably not a substantial claim. 25
  • It may state two separate claims as one. 26

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 11

Metadata

Authors
Wang, D., Zhang, G., Yu, Y., & Zhang, Z.
Affiliations
First Hospital of China Medical University (CN)
Corresponding author
  • Wang, Dingyue
  • Zhang, Gaosen
  • Yu, Yana
  • Zhang, Zhen
Venue
Clinical Interventions in Aging
Published
2024-01
Volume
Volume 19
Pages
141-151
ISSN
  • 1176-9092 (ISSN-L)
  • 1178-1998
OpenAlex
W4391271840
Cited by
11
References
103
Citations by year
2026: 4 · 2025: 7
FWCI
0.63
Type
journal article
Language
en
Open access
Locations
  • Clinical Interventions in Aging (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
sarcopenia, type 2 diabetes, skeletal muscle mass, muscle imaging, dual-energy X-ray absorptiometry, computed tomography, magnetic resonance imaging, ultrasound, diabetes complications, older adults
MeSH terms
Aged, Diabetes Mellitus, Type 2, Humans, Quality of Life, Muscle, Skeletal, Muscle Strength, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.